A safe and effective vaccine for primary prevention of HSV infection would be useful to control transmission, and several vaccines are currently in development and undergoing evaluation.

THE herpes simplex virus type 1 is best known as the villain behind the dreaded cold sore. When it’s not triggering eruptions ...

Penn has designed mRNA vaccines to prevent Lyme disease, norovirus, and herpes simplex virus 2. Penn is also studying how mRNA can treat sickle cell disease, deadly food allergies, and even cancer ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. Herpes simplex virus (HSV) is a common—and one ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...

Penn is also looking at designing mRNA vaccines for Lyme disease, norovirus, herpes simplex virus 2, sickle cell disease, deadly food allergies and cancer.

COVID and flu season is coming sooner than you might think, and getting up to date with vaccines is the best way to protect yourself in the months ahead. This year’s COVID vaccine is a little ...

Genital herpes infections and their related complications lead to billions of dollars in health care expenditures and productivity losses globally, according to the first ever global estimates of ...

Herpes simplex virus type 1 (HSV-1), the cause of the common cold sore, can spread into the central nervous system and preferences for certain parts of the brain. Study results published today in ...

Some weeks Laja is doing outreach, spending her day educating a community about which vaccines she can provide and what diseases they prevent. “It’s my responsibility to tell the mothers to ...